Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04114994 · ClinicalTrials.gov registry record
Longitudinal Cognitive Assessment by BoCA
A clinical trial of Multiple Sclerosis and Alzheimer Disease, sponsored by Alzheimer's Light.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT04114994 is a study of Multiple Sclerosis and Alzheimer Disease that is actively recruiting participants, run by Alzheimer's Light. The registered enrollment target is 10,000 participants, above the 553-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (1708% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04114994, a study of Multiple Sclerosis and Alzheimer Disease, is actively recruiting participants, sponsored by Alzheimer's Light.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Boston Cognitive Assessment (BoCA)
Study Locations (1)
Florida
- Andrey Vyshedskiy - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2029-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04114994
The ClinicalTrials.gov registry entry for NCT04114994 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 553-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (1708% higher). The listed sponsor is Alzheimer's Light, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Boston Cognitive Assessment (BoCA) is the first listed.
NCT04114994 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04114994 about?
NCT04114994 is a clinical study titled "Longitudinal Cognitive Assessment by BoCA". The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to...
What is the current status of trial NCT04114994?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2019-10-01. Estimated completion is 2029-10-01.
What conditions does trial NCT04114994 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Alzheimer Disease, Parkinson Disease, Mild Cognitive Impairment, Frontotemporal Dementia.
What interventions are being tested in trial NCT04114994?
The interventions under investigation include: Boston Cognitive Assessment (BoCA) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04114994?
This trial is sponsored by Alzheimer's Light, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04114994 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.